NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, March 25th. Analysts expect NovaBay Pharmaceuticals to post earnings of ($0.19) per share and revenue of $2.50 million for the quarter.
NovaBay Pharmaceuticals Stock Performance
NovaBay Pharmaceuticals stock opened at $0.64 on Tuesday. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $9.08. The stock has a market capitalization of $2.71 million, a PE ratio of -0.06 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
See Also
- Five stocks we like better than NovaBay Pharmaceuticals
- Stock Market Sectors: What Are They and How Many Are There?
- Can TikTok Stock Picks Really Make You Rich?
- About the Markup Calculator
- The “Quality” Rotation: Back to Basics Investing
- Which Wall Street Analysts are the Most Accurate?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.